# Laboratory module completeness audit

**Audit date:** 2026-10-12  
**Scope:** Repository UI, migration history, and read-only inspection of the connected Supabase schema. No live database writes or migrations were executed.

## Finding

The repository has a useful laboratory workflow foundation, but it is **not yet a complete production LIS**. It already includes test catalogue basics, encounter-linked ordering, a payment/release gate, sample collection, single-value result entry, a structured-result RPC, result approval, clinician-facing approved results, acknowledgement, and outside-laboratory document/AI-analysis foundations. The front-end did not use the existing structured-result RPC, and the active catalogue-creation form could not define structured parameters.

The live database query for active catalogue entries returned **zero rows**. This is an operational configuration gap, not a reason to invent clinical reference ranges or seed unapproved test definitions.

## Implemented in this change set

- Structured parameter inputs are rendered from catalogue definitions and submitted through `enter_lab_result_structured`; existing single-value tests retain `enter_lab_result`.
- Required structured parameters are checked in the UI and remain independently enforced by the database RPC.
- Catalogue creation accepts parameter JSON and uses a new authenticated RPC that validates array shape, unique codes, supported types, required flags, and reference-bound ordering.
- Structured parameter values are shown in the order details.
- Order creation, specimen collection, result submission, and approval guard duplicate actions and handle transport rejections.
- The laboratory workspace loading state always clears after failure.
- A new migration scopes patient, order, and result reads to the active facility. It deliberately excludes unresolved legacy rows with missing facility attribution rather than guessing their facility.
- Regression contracts are included in the required test chain.

## Confirmed remaining functional gaps

These require additional implementation and validation before claiming production LIS completeness:

1. **Specimen accessioning and traceability:** existing order fields include collection timestamp and collector, but no dedicated specimen/accession entity, barcode/label, container, received-at, rejected-at/reason, recollection, aliquot, transport, or chain-of-custody events.
2. **Quality control and instrument workflow:** no complete QC lot/control run, calibration, instrument mapping, analyzer interface, result import queue, duplicate-message/idempotency, or interface exception worklist was identified in the inspected lab schema.
3. **Critical-value escalation:** abnormal flags and clinician notifications exist, but the inspected schema does not provide a distinct critical-value acknowledgement/escalation policy with recipient routing, timers, escalation attempts, and closed-loop documentation.
4. **Amendment/version workflow:** result approval and acknowledgement exist, but there is no dedicated immutable result-version/correction workflow in the inspected result columns.
5. **Turnaround-time monitoring:** catalogue turnaround minutes exist, but the workspace does not yet calculate due times, breached SLAs, hold reasons, or overdue escalation.
6. **Microbiology and reflex workflows:** no full culture/organism/susceptibility, reflex testing, or panel-component lifecycle was identified in the inspected implementation.
7. **Catalogue operations:** structured parameters can now be created, but governed editing/deactivation/versioning, facility-specific reference ranges, age/sex/pregnancy-specific ranges, LOINC mapping, and catalogue approval workflow remain to be designed.
8. **Operational setup:** the live active catalogue query returned zero active test definitions. Before go-live, an authorized laboratory lead must approve the catalogue, units, specimen requirements, reference intervals, charges, and turnaround targets.
9. **End-to-end acceptance:** browser-level tests with seeded, non-production fixtures are still required for ordering, payment release, specimen collection, structured entry, approval, clinical notification/acknowledgement, permissions, and cross-facility denial.

## Safety constraints

- Do not invent reference ranges or populate a live clinical catalogue with unapproved data.
- Do not backfill null facility attribution automatically; use the governed reconciliation workflow.
- Do not apply the new migrations to the live Supabase project without explicit approval and a reviewed migration plan.
- Laboratory staff must verify test definitions, local reference intervals, critical thresholds, and analyzer mappings before clinical use.
- This audit is a source/schema assessment, not clinical validation, accreditation, or a production-readiness certification.
